Measuring of the duration of action of different doses of rocuronium-induced neuromuscular block in infants during surgical treatment of craniosynostosis - a prospective, case-controlled study
This study focuses on how a muscle-relaxing medicine, rocuronium, affects infants who are having surgery for craniosynostosis (when bones in a baby's skull join too early). Doctors want to find out how long different doses of rocuronium work and if other anaesthetic medicines, like sevoflurane or propofol, change how rocuronium acts in the body. The main goal is to understand these effects better so that doctors can safely give muscle relaxants and, just as importantly, safely reverse their effects when surgery is over. This knowledge is especially important for babies, as their bodies process medicines differently than adults.
At a glance
What is this study about?
When children have surgery, they often need medicines to help them sleep (anaesthesia) and to relax their muscles so the surgeon can operate safely. One such muscle-relaxing medicine is called rocuronium. This study is looking at how this specific medicine works in babies who are having a type of surgery called craniosynostosis. This is when the bones in a baby's skull join together too early.
The researchers in this study want to understand two main things: firstly, how long different amounts (doses) of rocuronium keep the muscles relaxed, and secondly, if other anaesthetic medicines that are commonly used during surgery, such as sevoflurane or propofol, change how rocuronium affects the baby's body. These other medicines might make rocuronium work for longer or differently.
By carefully watching how these medicines interact, doctors can learn how to use muscle relaxants and their reversal medicines more effectively and safely in very young children. This is vital because babies' bodies handle medicines differently than adults, and precise dosing is very important to ensure their safety and a smooth recovery after surgery.
Key takeaways
- Study examines muscle relaxant effects in babies having craniosynostosis surgery.
- Aims to understand how rocuronium works and interacts with other anaesthetic medicines.
- Information gained will improve safety and care for future babies needing surgery.
- Participation involves close monitoring during already planned surgery.
- No extra visits or changes to your baby's planned surgical care.
- It's a Phase IV study, meaning the medicines are already approved and in use.
Who may be eligible?
This study includes babies who are having surgery for a condition called craniosynostosis. Craniosynostosis is a birth defect where one or more of the joints between the bones of a baby's skull close too early. This can affect the shape of the baby's head and how their brain grows. The study includes both baby boys and baby girls.
There are no specific age limits mentioned beyond being an infant scheduled for this particular surgery. If your baby is undergoing surgery for craniosynostosis, they might be able to take part.
It's important to remember that the research team will look at each baby's medical history to make sure taking part is safe and right for them. They will check to see if there are any other health conditions that might prevent a baby from joining the study.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Is my baby undergoing surgery for craniosynostosis?
- Will my baby need standard anaesthesia during this surgery?
- Is my baby generally healthy enough for surgery?
- Am I comfortable with careful monitoring of medicines during their procedure?
What does participation involve?
If your baby takes part in this study, they will receive rocuronium as part of their anaesthesia during their planned craniosynostosis surgery. The study involves observing how different doses of rocuronium affect their muscles and how long the effect lasts. This will happen during the surgery itself, and doctors will carefully monitor your baby throughout the procedure.
They will also be looking at how other common anaesthetic medicines (like sevoflurane or propofol, which are standard for such surgeries) might interact with rocuronium. This is all part of the normal surgical process, but with extra careful monitoring of the muscle relaxant's effects.
There are no additional visits or follow-up appointments specifically for this study beyond what would normally be expected for your baby's surgery and recovery. The total duration of participation is limited to the time your baby is under anaesthesia during their surgery and immediate recovery.
Potential risks and benefits
Locations (1)
- —UnverifiedHungary
Common questions
What is craniosynostosis surgery?
It's a surgery for babies where skull bones have joined too early, to reshape their head and allow their brain to grow properly.
What is rocuronium?
It's a medicine used during surgery to temporarily relax muscles, making it safer for the surgeon to operate.
Will my baby get extra medicine?
No, your baby will receive standard anaesthetic medicines for their surgery, but the study will observe how these medicines work together.
Will this make my baby's surgery longer?
No, the study observations will happen during the planned surgery and shouldn't extend the length of the operation.
What happens if I don't want my baby to take part?
Your baby will still receive the best standard medical care, and their treatment will not be affected at all if you choose not to participate.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.